| dc.contributor.author | Taher, TE | en_US |
| dc.contributor.author | Muhammad, HA | en_US |
| dc.contributor.author | Rahim, A | en_US |
| dc.contributor.author | Flores-Borja, F | en_US |
| dc.contributor.author | Renaudineau, Y | en_US |
| dc.contributor.author | Isenberg, DA | en_US |
| dc.contributor.author | Mageed, RA | en_US |
| dc.date.accessioned | 2020-05-05T14:41:22Z | |
| dc.date.available | 2013-04-29 | en_US |
| dc.date.issued | 2013 | en_US |
| dc.identifier.issn | 0014-2972 | en_US |
| dc.identifier.uri | https://qmro.qmul.ac.uk/xmlui/handle/123456789/63946 | |
| dc.description.sponsorship | Isenberg and R. A. Mageed are supported by ArthritisResearch-UK. | en_US |
| dc.format.extent | 866 - 880 | en_US |
| dc.language.iso | en | en_US |
| dc.relation.ispartof | EUROPEAN JOURNAL OF CLINICAL INVESTIGATION | en_US |
| dc.subject | B-lymphocytes | en_US |
| dc.subject | immunopathology | en_US |
| dc.subject | lupus | en_US |
| dc.subject | signalling | en_US |
| dc.title | Aberrant B-lymphocyte responses in lupus: inherent or induced and potential therapeutic targets | en_US |
| dc.type | Article | |
| dc.rights.holder | Stichting European Society for Clinical Investigation Journal Foundation | |
| dc.identifier.doi | 10.1111/eci.12111 | en_US |
| pubs.author-url | https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000322012300013&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6a | en_US |
| pubs.issue | 8 | en_US |
| pubs.notes | Not known | en_US |
| pubs.publication-status | Published | en_US |
| pubs.volume | 43 | en_US |
| rioxxterms.funder | Default funder | en_US |
| rioxxterms.identifier.project | Default project | en_US |
| qmul.funder | Identification and defining the role of pathogenic B lymphocytes in patients with lupus::Versus Arthritis | en_US |
